Evaluation of Zofa herbal syrup in cough

Phase 3

Recruiting

• Conditions: post infection cough.

• Registration Number: IRCT20210508051215N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

All hospitalized patient with post-infection cough

Exclusion Criteria

Participating in another study
Known case of DM 1 & 2, seizure, pulmonary disease like asthma and COPD
Drug history of phenytoin, phenobarbital, gentamicin and venlafaxin
Symptoms like hemoptysis which may have special diagnosis
Pregnancy and lactation
Drug which may cause cough like ACEI
History of Rhinitis and allergy, GERD, smoking
Hypersensitivity to any ingredient of herbal syrup

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cough score in visual analogue scale. Timepoint: Day 1,2,7,14. Method of measurement: visual analogue scale.;Cough score in simplified cough score. Timepoint: Day 1,2,7,14. Method of measurement: Simplified cough score.;Score in cough symptom score. Timepoint: Day 1,2,7,14. Method of measurement: Cough symptom score.

Secondary Outcome Measures

Name	Time	Method
Data laboratory changes. Timepoint: Daily. Method of measurement: Data laboratory from blood sample.